MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, M. F.
Right arrow Articles by Eling, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, M. F.
Right arrow Articles by Eling, T. E.

Prostaglandin hydroperoxidase-dependent oxidation of phenylbutazone: relationship to inhibition of prostaglandin cyclooxygenase

MF Hughes, RP Mason and TE Eling

Curriculum in Toxicology, University of North Carolina, Chapel Hill 27514.

Prostaglandin H synthase (PHS) hydroperoxidase-mediated metabolism of phenylbutazone and the relationship of this metabolism to the inhibition of PHS cyclooxygenase by phenylbutazone was investigated. Phenylbutazone was metabolized to several intermediates and metabolites. A phenylbutazone carbon-centered radical (aN = 14.6 G) formed by PHS hydroperoxidase was trapped by 2-methyl-2-nitrosopropane and detected by ESR in incubations with ram seminal vesicle microsomes. 4-Hydroperoxy- and 4-hydroxyphenylbutazone were isolated from incubations of phenylbutazone with either ram seminal vesicle microsomes or horseradish peroxidase. Phenylbutazone (100 microM-2 mM) inhibited PHS cyclooxygenase in incubations of PHS apoenzyme reconstituted with hematin. Phenylbutazone (5-250 microM) did not inhibit PHS cyclooxygenase in incubations of PHS apoenzyme reconstituted with manganese protoporphyrin IX, which lacks hydroperoxidase activity. Thus, metabolism of phenylbutazone by PHS hydroperoxidase is required for it to inhibit PHS cyclooxygenase. 4- Hydroperoxy- and 4-hydroxyphenylbutazone were ineffective inhibitors of PHS cyclooxygenase. Other hydroperoxides that easily rearrange to peroxyl radicals were potent inhibitors of PHS cyclooxygenase, suggesting that the phenylbutazone peroxyl radical may be the inhibitor. 4-Hydroperoxyphenylbutazone was not reduced to 4- hydroxyphenylbutazone by PHS hydroperoxidase. We propose that 4- hydroxyphenylbutazone formation occurs by a nonenzymatic reaction of two phenylbutazone peroxyl radicals and their subsequent rearrangement to alkoxy radicals, which abstract hydrogen atoms. Our data indicate the importance of PHS hydroperoxidase in the inactivation of PHS cyclooxygenase by peroxides.

Volume 34, Issue 2, pp. 186-193, 08/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics